Elsässer A - Search Results

1

Effects of 2-deoxy-D-glucose on proliferation of vascular smooth muscle cells and endothelial cells.

Nef HM, Möllmann H, Joseph A, Troidl C, Voss S, Vogt A, Weber M, Hamm CW, Elsässer A. Nef HM, et al. Among authors: elsasser a. J Int Med Res. 2008 Sep-Oct;36(5):986-91. doi: 10.1177/147323000803600515. J Int Med Res. 2008. PMID: 18831892 Free article.

2

Assessment of myocardial viability: Dobutamine echocardiography and thallium-201 single-photon emission computed tomographic imaging predict the postoperative improvement of left ventricular function after bypass surgery.

Elsässer A, Müller KD, Vogt A, Strasser R, Gagel C, Schlepper M, Klövekorn WP. Elsässer A, et al. Am Heart J. 1998 Mar;135(3):463-75. doi: 10.1016/s0002-8703(98)70323-0. Am Heart J. 1998. PMID: 9506333

3

Lack of adenosine causes myocardial refractoriness.

Vogt AM, Ando H, Arras M, Elsässer A. Vogt AM, et al. Among authors: elsasser a. J Am Coll Cardiol. 1998 Apr;31(5):1134-41. doi: 10.1016/s0735-1097(98)00061-8. J Am Coll Cardiol. 1998. PMID: 9562019 Free article.

4

Metabolic control analysis of anaerobic glycolysis in human hibernating myocardium replaces traditional concepts of flux control.

Vogt AM, Nef H, Schaper J, Poolman M, Fell DA, Kübler W, Elsässer A. Vogt AM, et al. Among authors: elsasser a. FEBS Lett. 2002 Apr 24;517(1-3):245-50. doi: 10.1016/s0014-5793(02)02632-7. FEBS Lett. 2002. PMID: 12062446 Free article. Clinical Trial.

5

Increased glycolysis as protective adaptation of energy depleted, degenerating human hibernating myocardium.

Vogt AM, Elsässer A, Nef H, Bode C, Kübler W, Schaper J. Vogt AM, et al. Among authors: elsasser a. Mol Cell Biochem. 2003 Jan;242(1-2):101-7. Mol Cell Biochem. 2003. PMID: 12619871

6

Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death.

Elsässer A, Vogt AM, Nef H, Kostin S, Möllmann H, Skwara W, Bode C, Hamm C, Schaper J. Elsässer A, et al. J Am Coll Cardiol. 2004 Jun 16;43(12):2191-9. doi: 10.1016/j.jacc.2004.02.053. J Am Coll Cardiol. 2004. PMID: 15193679 Free article.

7

[Oral antithrombotic therapy in primary and secondary prevention].

Möllmann H, Elsässer A, Hamm CW. Möllmann H, et al. Among authors: elsasser a. Herz. 2005 May;30(3):181-8. doi: 10.1007/s00059-005-2682-9. Herz. 2005. PMID: 15902368 Review. German.

8

Clopidogrel in acute coronary syndrome: when, how much, how long?

Elsässer A, Nef H, Möllmann H, Hamm CW. Elsässer A, et al. Z Kardiol. 2005 Jun;94(6):377-82. doi: 10.1007/s00392-005-0224-3. Z Kardiol. 2005. PMID: 15940437 Review.

9

Transcatheter closure of a ruptured ventricular septum after myocardial infarction using a venous approach.

Elsässer A, Möllmann H, Nef H, Dill T, Brandt R, Skwara W, Hennig T, Rau M, Hamm C. Elsässer A, et al. Z Kardiol. 2005 Oct;94(10):684-9. doi: 10.1007/s00392-005-0274-6. Z Kardiol. 2005. PMID: 16200484

10

Metabolic control analysis of the Warburg-effect in proliferating vascular smooth muscle cells.

Werle M, Kreuzer J, Höfele J, Elsässer A, Ackermann C, Katus HA, Vogt AM. Werle M, et al. Among authors: elsasser a. J Biomed Sci. 2005 Oct;12(5):827-34. doi: 10.1007/s11373-005-9010-5. Epub 2005 Nov 9. J Biomed Sci. 2005. PMID: 16205843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters